Ondas Inc. is caught in a tightening vice: the borrow market has locked up completely for the second time in a month, short interest is grinding toward 44% of the float, and the CEO recently sold $32 million worth of stock into what was then a higher price.
The lending picture is the sharpest signal right now. Availability has fallen back to 0% — every share in the pool is on loan — after a brief window of relief that peaked near 12.7% on June 5. That window closed fast. Availability dropped from 11.3% on June 10 to 5.3% on June 11, 2.4% on June 12, 0.7% on June 15, and zero on June 16. Short interest has moved in lockstep, rising 4.5% on the week to just under 44% of the free float — the highest reading in the current data window. What remains a notable disconnect is the cost to borrow: at 1.55%, it ticked up only 5% on the week and sits well below the 2.2% spikes seen in early June. With availability fully exhausted, that CTB number is not reflecting the degree of squeeze in the pool — new short demand simply cannot be met. The ORTEX short score has ground steadily higher all week, reaching 69.5 on June 16, its peak for the trailing 10-day window.
Options positioning cuts the other way. Call sentiment is running slightly above normal, with the put/call ratio at 0.44 — about 1.3 standard deviations below its 20-day mean of 0.47. That is modestly call-heavy, not the defensive posture you might expect given the borrow conditions. The PCR has drifted steadily lower from the 0.50–0.51 range seen through May, suggesting options traders are leaning into recovery scenarios rather than hedging for further downside. The contrast with the lending market is genuine: the borrow pool is locked, but options buyers are not fleeing.
The insider angle adds weight to the bearish case. CEO Eric Brock sold 2.38 million shares on June 2 for roughly $31.9 million at $13.43 — a price the stock has since fallen well below, closing at $9.21 on June 16, a 13% drop on the month. That sale followed a 4.5 million share award granted to him the day prior. Directors also sold smaller lots on May 20 at $9.70, alongside the CFO. The 90-day net insider position, stripping out the non-cash award, is a seller: net value transferred out is approximately $32.6 million. At the current price, buyers of those director sales are underwater.
The Street's few active analysts remain constructive on paper but the gap between targets and price is wide. Needham reiterated its Buy with a $23 target as recently as May 19 — more than 150% above the current price. Northland lifted its target to $18 in late March. All recent analyst moves have been maintained or raised, and there are no downgrades on record in this cycle. The bull case rests on autonomous systems growth and digital transformation exposure. The bear case, well articulated by prior notes, centers on acquisition-dependent revenue, uneven commercial adoption, defense budget unpredictability, and cash sustainability questions around the Omnisys deal. The ORTEX short score rank of 2 out of 100 — near the bottom of the universe — and a utilization rank of 0 confirm the positioning picture: this is among the most heavily shorted, least-available stocks in the screened universe. Earnings are not due until August 14, leaving the next six weeks without a fundamental catalyst.
The key dynamics to watch are whether the borrow pool stays locked at zero availability or cracks open again as it briefly did in early June, and whether the widening gap between analyst targets and the current price draws in institutional buyers willing to push against the short interest — or simply prompts target revisions downward.
See the live data behind this article on ORTEX.
Open ONDS on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
